Original Article
28 June 2017 / 17 April 2024 by almaware | Leave a Comment
Read more »
Letter to the Editor
Case Report
27 June 2017 / 17 April 2024 by almaware | Leave a Comment
Review
27 June 2017 / 23 May 2024 by almaware | Leave a Comment
Monoclonal anti-IgE antibodies (omalizumab) are able to induce clinically significant benefits in patients with severe chronic spontaneous urticaria (CS). Those results led clinicians and investigators to reconsider a possible pathogenic role not previously supported for IgE and its receptors in this disease, and to investigate additional approaches for understanding its pathogenesis. IgE antibodies to unknown […]